Vismodegib in real-life clinical settings: A multicenter, longitudinal cohort providing long-term data on efficacy and safety

被引：4

作者：

Apalla, Zoe ^{[1
]}

Spyridis, Ioannis ^{[2
]}

Kyrgidis, Athanassios ^{[3
]}

Lazaridou, Elizabeth ^{[1
]}

Kyriakou, Aikaterini ^{[1
]}

Fotiadou, Christina ^{[1
]}

Pikou, Olga ^{[1
]}

Sotiriou, Elena ^{[1
]}

Vakirlis, Efstratios ^{[2
]}

Papageorgiou, Chryssoula ^{[2
]}

Delli, Florentina ^{[4
]}

Moutsoudis, Andreas ^{[2
]}

Manoli, Sofia Magdalini ^{[2
]}

Ioannides, Dimitrios ^{[2
]}

Lallas, Aimilios ^{[2
]}

机构：

[1] Aristotle Univ Thessaloniki, Dept Dermatol 2, Thessaloniki, Greece

[2] Aristotle Univ Thessaloniki, Dept Dermatol 1, Thessaloniki, Greece

[3] Aristotle Univ Thessaloniki, Sch Med, Dept Clin Pharmacol, Thessaloniki, Greece

[4] Hippokratio Gen Hosp Thessaloniki, State Dermatol Dept, Thessaloniki, Greece

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 06期

关键词：

HEDGEHOG PATHWAY INHIBITOR;

D O I：

10.1016/j.jaad.2020.11.036

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：1589 / 1592

页数：4

共 50 条

[21] Long-term (>48 weeks) safety and tolerability of erenumab in real-life
Aurilia, Cinzia
Egeo, Gabriella
Fofi, Luisa
Cevoli, Sabina
Messina, Roberta
Salerno, Antonio
Torelli, Paola
Albanese, Maria
Carnevale, Antonio
Bono, Francesco
D'Amico, Domenico
Filippi, Massimo
Altamura, Claudia
Vernieri, Fabrizio
Colombo, Bruno
Frediani, Fabio
Mercuri, Bruno
D'Onofrio, Florindo
Grazzi, Licia
Aguggia, Marco
Favoni, Valentina
Finocchi, Cinzia
Di Fiore, Paola
Costa, Carlemina Maria
Brunelli, Nicoletta
Fallacara, Adriana
Bertuzzo, Davide
Zucco, Maurizio
Di Clemente, Laura
Trimboli, Michele
Pascarella, Angelo
Manzo, Lucia
Barbanti, Piero
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 210 - 210
[22] Long-term (>48 weeks) safety and tolerability of erenumab in real-life
Aurilia, C.
Cevoli, S.
Egeo, G.
Fofi, L.
Messina, R.
Salerno, A.
Torelli, P.
Albanese, M.
Carnevale, A.
Bono, F.
D'Amico, D.
Filippi, M.
Altamura, C.
Vernieri, F.
Colombo, B.
Frediani, F.
Mercuri, B.
D'Onofrio, F.
Grazzi, L.
Aguggia, M.
Favoni, V.
Finocchi, C.
Di Fiore, P.
Costa, C. M.
Brunelli, N.
Fallacara, A.
Bertuzzo, D.
Zucco, M.
Di Clemente, L.
Trimboli, M.
Pascarella, A.
Manzo, L.
Barbanti, P.
JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 124 - 124
[23] Real-life long-term efficacy of dupilumab in adults with moderate to severe atopic dermatitis: Results of a cohort study
Guedon, C.
Tauber, M.
Linder, C.
Paul, C.
Shourick, J.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2023, 150 (03): : 215 - 216
[24] Short and long-term efficacy of adalimumab in ulcerative colitis: a real-life study
Angelison, Leif
Almer, Sven
Davidsdottir, Loa
Hammarlund, Per
Lindgren, Stefan
Hindorf, Ulf
Marsal, Jan
Hertervig, Erik
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (02) : 154 - 162
[25] Long term (1-year) effectiveness, safety and tolerability of fremanezumab in migraine: a real-life, prospective, cohort, multicenter study
Egeo, Gabriella
Aurilia, Cinzia
Orlando, Bianca
Fiorentini, Giulia
D'Onofrio, Florindo
Albanese, Maria
Messina, Roberta
Di Fiore, Paola
Zucco, Maurizio
Filippi, Massimo
Bartolini, Marco
Bono, Francesco
Grazzi, Licia
Querzani, Pietro
Borrello, Laura
Doretti, Alberto
Gai, Annalisa
Proietti, Stefania
Bonassi, Stefano
Vernieri, Fabrizio
Torelli, Paola
Barbanti, Piero
CEPHALALGIA, 2023, 43 (1supp) : 257 - 258
[26] Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial
Yorgancioglu, Arzu
Erkekol, Ferda Oner
Mungan, Dilsad
Erdinc, Munevver
Gemicioglu, Bilun
Ozseker, Zeynep Ferhan
Degirmenci, Papatya Bayrak
Nayci, Sibel
Cilli, Aykut
Erdenen, Fusun
Kirmaz, Cengiz
Ediger, Dane
Yalcin, Arzu Didem
Buyukozturk, Suna
Ozturk, Sami
Gulec, Mustafa
Isik, Sacide Rana
Kalyoncu, Ali Fuat
Goksel, Ozlem
Aydin, Omur
Havlucu, Yavuz
Ar, Idilhan Baloglu
Erdogdu, Ahmet
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2018, 176 (3-4) : 225 - 233
[27] LONG-TERM EFFICACY AND SAFETY OF VEDOLIZUMAB IN IBD PATIENTS: A REAL-LIFE EXPERIENCE FROM A TERTIARY REFERRAL CENTER
Dragoni, G.
Zu Schwabedissen, A. Meyer
Manetti, N.
Le Grazie, M.
Campani, C.
Bensi, C.
Galli, A.
Bagnoli, S.
Milla, M.
DIGESTIVE AND LIVER DISEASE, 2019, 51 : E240 - E241
[28] Long-Term Efficacy and Safety of Atazanavir/Ritonavir Treatment in a Real-Life Cohort of Treatment-Experienced Patients with HIV Type 1 Infection
Jansen, Klaus
Sonnerborg, Anders
Brockmeyer, Norbert
Thalme, Anders
Svedhem, Veronica
Dupke, Stephan
Eychenne, Jean-Luc
Nakonz, Tina
Jimenez-Exposito, Maria Jesus
Pugliese, Pascal
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (03) : 564 - 573
[29] Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study
Patruno, Cataldo
Fabbrocini, Gabriella
Longo, Giuseppe
Argenziano, Giuseppe
Ferrucci, Silvia Mariel
Stingeni, Luca
Peris, Ketty
Ortoncelli, Michela
Offidani, Annamaria
Amoruso, Giuseppe Fabrizio
Talamonti, Marina
Girolomoni, Giampiero
Grieco, Teresa
Iannone, Michela
Nettis, Eustachio
Foti, Caterina
Rongioletti, Franco
Corazza, Monica
Veneri, Michele Delli
Napolitano, Maddalena
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (04) : 581 - 586
[30] Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study
Cataldo Patruno
Gabriella Fabbrocini
Giuseppe Longo
Giuseppe Argenziano
Silvia Mariel Ferrucci
Luca Stingeni
Ketty Peris
Michela Ortoncelli
Annamaria Offidani
Giuseppe Fabrizio Amoruso
Marina Talamonti
Giampiero Girolomoni
Teresa Grieco
Michela Iannone
Eustachio Nettis
Caterina Foti
Franco Rongioletti
Monica Corazza
Michele Delli Veneri
Maddalena Napolitano
American Journal of Clinical Dermatology, 2021, 22 : 581 - 586

← 1 2 3 4 5 →